Literature DB >> 26124280

Analysis of the Role of the C-Terminal Tail in the Regulation of the Epidermal Growth Factor Receptor.

Erika Kovacs1, Rahul Das1, Qi Wang1, Timothy S Collier2, Aaron Cantor1, Yongjian Huang1, Kathryn Wong1, Amar Mirza3, Tiago Barros1, Patricia Grob4, Natalia Jura5, Ron Bose2, John Kuriyan6.   

Abstract

The ∼230-residue C-terminal tail of the epidermal growth factor receptor (EGFR) is phosphorylated upon activation. We examined whether this phosphorylation is affected by deletions within the tail and whether the two tails in the asymmetric active EGFR dimer are phosphorylated differently. We monitored autophosphorylation in cells using flow cytometry and found that the first ∼80 residues of the tail are inhibitory, as demonstrated previously. The entire ∼80-residue span is important for autoinhibition and needs to be released from both kinases that form the dimer. These results are interpreted in terms of crystal structures of the inactive kinase domain, including two new ones presented here. Deletions in the remaining portion of the tail do not affect autophosphorylation, except for a six-residue segment spanning Tyr 1086 that is critical for activation loop phosphorylation. Phosphorylation of the two tails in the dimer is asymmetric, with the activator tail being phosphorylated somewhat more strongly. Unexpectedly, we found that reconstitution of the transmembrane and cytoplasmic domains of EGFR in vesicles leads to a peculiar phenomenon in which kinase domains appear to be trapped between stacks of lipid bilayers. This artifactual trapping of kinases between membranes enhances an intrinsic functional asymmetry in the two tails in a dimer.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26124280      PMCID: PMC4525312          DOI: 10.1128/MCB.00248-15

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

1.  Cerulean, Venus, and VenusY67C FRET reference standards.

Authors:  Srinagesh V Koushik; Huanmian Chen; Christopher Thaler; Henry L Puhl; Steven S Vogel
Journal:  Biophys J       Date:  2006-10-13       Impact factor: 4.033

2.  In-gel digestion for mass spectrometric characterization of proteins and proteomes.

Authors:  Andrej Shevchenko; Henrik Tomas; Jan Havlis; Jesper V Olsen; Matthias Mann
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

3.  Mechanism of biological synergy between cellular Src and epidermal growth factor receptor.

Authors:  D A Tice; J S Biscardi; A L Nickles; S J Parsons
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 4.  Molecular mechanisms of SH2- and PTB-domain-containing proteins in receptor tyrosine kinase signaling.

Authors:  Melany J Wagner; Melissa M Stacey; Bernard A Liu; Tony Pawson
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

Review 5.  The EGFR family: not so prototypical receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger; Kathryn M Ferguson
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-04-01       Impact factor: 10.005

6.  Improved side-chain torsion potentials for the Amber ff99SB protein force field.

Authors:  Kresten Lindorff-Larsen; Stefano Piana; Kim Palmo; Paul Maragakis; John L Klepeis; Ron O Dror; David E Shaw
Journal:  Proteins       Date:  2010-06

7.  Mechanistic insights into the activation of oncogenic forms of EGF receptor.

Authors:  Zhihong Wang; Patti A Longo; Mary Katherine Tarrant; Kwangsoo Kim; Sarah Head; Daniel J Leahy; Philip A Cole
Journal:  Nat Struct Mol Biol       Date:  2011-11-20       Impact factor: 15.369

8.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

9.  Architecture and membrane interactions of the EGF receptor.

Authors:  Anton Arkhipov; Yibing Shan; Rahul Das; Nicholas F Endres; Michael P Eastwood; David E Wemmer; John Kuriyan; David E Shaw
Journal:  Cell       Date:  2013-01-31       Impact factor: 41.582

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  35 in total

1.  Src defines a new pool of EGFR substrates.

Authors:  Nicole Michael; Natalia Jura
Journal:  Nat Struct Mol Biol       Date:  2015-12       Impact factor: 15.369

2.  Method to Visualize and Analyze Membrane Interacting Proteins by Transmission Electron Microscopy.

Authors:  Ramakrishnan B Kumar; Lin Zhu; Hans Hebert; Caroline Jegerschöld
Journal:  J Vis Exp       Date:  2017-03-05       Impact factor: 1.355

3.  Biophysical Evidence for Intrinsic Disorder in the C-terminal Tails of the Epidermal Growth Factor Receptor (EGFR) and HER3 Receptor Tyrosine Kinases.

Authors:  Theodore R Keppel; Kwabena Sarpong; Elisa M Murray; John Monsey; Jian Zhu; Ron Bose
Journal:  J Biol Chem       Date:  2016-11-21       Impact factor: 5.157

4.  In-cell structural dynamics of an EGF receptor during ligand-induced dimer-oligomer transition.

Authors:  Noga Kozer; Andrew H A Clayton
Journal:  Eur Biophys J       Date:  2019-11-18       Impact factor: 1.733

5.  EGFR forms ligand-independent oligomers that are distinct from the active state.

Authors:  Patrick O Byrne; Kalina Hristova; Daniel J Leahy
Journal:  J Biol Chem       Date:  2020-07-29       Impact factor: 5.157

6.  EGF and NRG induce phosphorylation of HER3/ERBB3 by EGFR using distinct oligomeric mechanisms.

Authors:  Bettina van Lengerich; Christopher Agnew; Elias M Puchner; Bo Huang; Natalia Jura
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-20       Impact factor: 11.205

7.  Regulation of Kinase Activity in the Caenorhabditis elegans EGF Receptor, LET-23.

Authors:  Lijun Liu; Tarjani M Thaker; Daniel M Freed; Nicole Frazier; Ketan Malhotra; Mark A Lemmon; Natalia Jura
Journal:  Structure       Date:  2018-01-18       Impact factor: 5.006

8.  Phosphorylation-Dependent Conformations of the Disordered Carboxyl-Terminus Domain in the Epidermal Growth Factor Receptor.

Authors:  Raju Regmi; Shwetha Srinivasan; Andrew P Latham; Vandna Kukshal; Weidong Cui; Bin Zhang; Ron Bose; Gabriela S Schlau-Cohen
Journal:  J Phys Chem Lett       Date:  2020-11-12       Impact factor: 6.475

9.  Combination of a STAT3 Inhibitor and an mTOR Inhibitor Against a Temozolomide-resistant Glioblastoma Cell Line.

Authors:  Haruo Miyata; Tadashi Ashizawa; Akira Iizuka; Ryota Kondou; Chizu Nonomura; Takashi Sugino; Kenichi Urakami; Akira Asai; Nakamasa Hayashi; Koichi Mitsuya; Yoko Nakasu; Ken Yamaguchi; Yasuto Akiyama
Journal:  Cancer Genomics Proteomics       Date:  2017-01-02       Impact factor: 4.069

10.  Expanding the search for significant EGFR mutations in NSCLC outside of the tyrosine kinase domain with next-generation sequencing.

Authors:  Matthew K Stein; Lindsay Morris; Jennifer L Sullivan; Moon Fenton; Ari VanderWalde; Lee S Schwartzberg; Mike G Martin
Journal:  Med Oncol       Date:  2017-06-01       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.